Syndax Pharma Prices Public Offering Of About 6.82 Mln Shares At $22.00/shr

Syndax Pharmaceuticals Inc. (SNDX) said that it has priced an underwritten public offering of about 6.82 million shares of its common stock at $22.00 per share.

The aggregate gross proceeds from the offering are expected to be approximately $150.0 million, before deducting underwriting discounts and commissions and other offering expenses payable by Syndax.

In addition, Syndax granted the underwriters a 30-day option to purchase up to an additional 1.02 million shares of common stock. The offering is expected to close on December 9, 2022, subject to customary closing conditions.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Drug major Pfizer Inc. reported Tuesday higher earnings in its fourth quarter, above market estimates, and an all-time high revenues in its fiscal 2022. Meanwhile, the company projects sharply lower adjusted earnings and revenues in its fiscal 2023, below Wall Street estimates, reflecting projected decline for COVID-19 products. In pre-market activity on the NYSE, Pfizer shares were losing around Oil major Exxon Mobil Corp. (XOM) reported Tuesday that fourth-quarter net income was $12.75 billion or $3.09 per share, up from $8.87 million or $2.08 per share in the prior-year quarter. Excluding special items, adjusted earnings were $3.40 per share, compared to $2.05 per share in the prior-year... La Mirada, California-based Daiso California LLC is recalling certain Matsunaga Mini Shiruko Sand Biscuits citing undeclared soy, an allergen, the U.S. Food and Drug Administration said. The recall incolves Matsunaga Mini Shiruko Sand Biscuits with sku 4902773016966, packaged in four pink and cream bags chained together. Each individual serving is 25g for an entire product weight of 100g.
Follow RTT